Status: Enrolling
Investigator: Arvind Bhimaraj
Study Coordinator: Arati Bhosale
Phone: 713.441.3910
The objective of this registry is to observe short and long term clinical outcomes in heart transplant recipients who receive regular AlloMap testing as part of allograft rejection surveillance ... Read more >
Status: Enrolling
Investigator: Richard Knight
Study Coordinator: Joel Cisneros
Phone: 713.441.6311
The purpose of this study is to evaluate the efficacy of ASP0113 compared to placebo in reducing the incidence of cytomegalovirus (CMV) viremia in CMV-seronegative subjects receiving a kidney from a CMV-seropositive donor. This study will also e ... Read more >
Status: Enrolling
Investigator: Richard Knight
Study Coordinator: Joel Cisneros
Phone: 713.441.6311
The primary purpose is to assess the benefits and risks of changing from Cyclosporine or Tacrolimus to Belatacept between 6-36 months after kidney transplant. ... Read more >
Status: Enrolling
Investigator: Ahmed Gaber
Study Coordinator: Joy Nolte
Phone: 713.441.6314
BK infection is an important cause of graft dysfunction and graft loss after renal transplantation. It has been widely accepted that emergence of BK virus correlates with the more potent immunosuppressive agents used to lower acute rejection rat ... Read more >
Status: Enrolling
Investigator: Ahmed Gaber
Study Coordinator: Alejandro De La Torre
Phone: 000.000.0000
The purpose of this treatment registry study is to determine if monthly infusions of Intravenous Immunoglobulin (IVIg) for 6 months will neutralize donor specific antibodies that are thought to be responsible for chronic rejection episodes in re ... Read more >
Status: Enrolling
Investigator: Ahmed Gaber
Study Coordinator: Darrel Cleere
Phone: 713.441.6232
Rabbit antithymocyte globulin (rATG) is approved for the treatment of acute rejection following kidney transplantation and is routinely administered as a series of 5-7 consecutive daily doses via central intravenous catheter. This prolonged cour ... Read more >
Status: Open Not Enrolling
Investigator: Jean Bismuth
Study Coordinator: Kim Donlon
Phone: 713.441.9394
The purpose of this post-approval study is to evaluate the long-term performance of the GORE TAG® Thoracic Endoprosthesis (TAG device) in the primary treatment of descending thoracic aortic (DTA) aneurysms ... Read more >
Status: Enrolling
Investigator: Patrick Reardon
Study Coordinator: Yarley Perry
Phone: 713.796.0500ext134
To compare mechanical sphincter augmentation (LINX Reflux Management System) to double-dose proton pump inhibitors (PPIs) for the management of reflux symptoms related to gastroesophageal reflux disease (GERD). ... Read more >
Status: Enrolling
Investigator: Richard Knight
Study Coordinator: Joy Nolte
Phone: 713.441.6314
This is a 2-year, randomized, multicenter, open-label, 2-arm study evaluating the graft function of everolimus and reduced CNI versus MPA and standard CNI in adult de novo renal transplant recipients. ... Read more >
Status: Open Not Enrolling
Investigator: Jerry Estep
Study Coordinator: Arati Bhosale
Phone: 713.441.3910
This study will investigate the efficacy, safety, and tolerability of an oral dose of 20 mg or 80 mg tafamidis meglumine soft gel capsules in comparison to placebo and given once daily, in addition to standard of care, for 30 months in subjects ... Read more >
